AAM: Medicare Part D plans slow to adopt generics

Regulatory News

Regulatory NewsJeff Craven

Advertising, Promotion and LabelingBiologics/ biosimilars/ vaccinesNorth AmericaOtherPharmaceuticalsProduct LifecycleRegulatory Intelligence/Policy